Retatrutide is a triple agonist peptide compound belonging to the huma peptides category. This innovative weight loss peptide demonstrates enhanced glycemic control and weight reduction effects in preclinical studies.
As a glucagon-like peptide-1 (GLP-1) agonist, huma peptides retatrutide activates multiple receptor pathways to support metabolic regulation. The compound also functions as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptor agonist.
Our huma peptides retatrutide is produced under strict GMP standards, ensuring consistent quality for research applications. The freeze-dried powder form maintains excellent stability when stored properly.
This huma peptides product is intended for laboratory research purposes only. Not for human consumption or diagnostic use. Researchers should handle all peptide compounds with appropriate safety precautions.